Trials / Terminated
TerminatedNCT00778063
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Ochsner Health System · Academic / Other
- Sex
- All
- Age
- 1 Year – 5 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the use of intranasal dexmedetomidine to reduce the incidence of emergence delirium during general sevoflurane anesthesia in a pediatric population receiving pressure equalization tubes in one or more ear.
Detailed description
Emergence delirium has been described as a dissociated state of consciousness in which the child is irritable, uncompromising, uncooperative, incoherent, inconsolably crying, moaning, kicking or thrashing. The children can run the gambit from restlessness and incoherence to combative and psychotic. The incidence of emergence agitation or delirium is 80% after a procedure with sevoflurane-induced anesthesia. Dexmedetomidine has been shown to have sedative and analgesic effects. In the pediatric population, it has been shown to provide sedation for radiographic procedures. Intravenously, it is has been shown to decrease emergence delirium following sevoflurane based anesthesia. The ability to administer a medication intranasally might solve the problem of emergence delirium and emergence agitation posed by the young patients undergoing myringotomy and tube placement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexmedetomidine | 2 mcg/kg intranasally 30 minutes prior to surgery |
| DRUG | saline | a volume of intranasal saline, calculated based on body weight, will be given 30 minutes prior to surgery |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2008-10-23
- Last updated
- 2023-04-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00778063. Inclusion in this directory is not an endorsement.